Sohm Inc (SHMN)

$0.00 0.00 (-9.09%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,714,500
Avg Vol 1,906,366
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 0%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technol...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 714-522-6700
Fax: 714-523-4329
Address:
4740 Green River Road, Suite 307, Corona, United States
OckhamsRazor44
OckhamsRazor44 Jun. 29 at 6:12 PM
$SHMN Updates should be coming this summer
0 · Reply
OckhamsRazor44
OckhamsRazor44 Jun. 17 at 5:16 PM
$SHMN https://www.newswire.com/news/sohm-inc-awarded-european-patent-for-innovative-abbie-genome-editing-technology
0 · Reply
OckhamsRazor44
OckhamsRazor44 Jun. 17 at 5:16 PM
$SHMN This will come into play on SHMN sooner or later https://www.newswire.com/news/sohm-inc-awarded-european-patent-for-innovative-abbie-genome-editing-technology
0 · Reply
shortlongman
shortlongman Jun. 11 at 8:00 PM
$SHMN Or $TIPS
0 · Reply
OckhamsRazor44
OckhamsRazor44 Jun. 11 at 4:35 PM
$SHMN SHMN 💥 catalysts: "We are thrilled to introduce this game-changing technology to the world," said Dr. David Aguilar, Ph.D., SOHM’s COO. "Graphene nanoparticles have the potential to revolutionize genome editing, offering unprecedented precision and efficiency. We believe this breakthrough will have a profound impact on human health and open up new possibilities for scientific research as more gene therapies continue to pass FDA approvals."
0 · Reply
OckhamsRazor44
OckhamsRazor44 Jun. 11 at 2:50 PM
$SHMN 13M+ volume SHMN before 1 hour of trading. Someone loading. Something up. Someone or a group loading. Then 23M shares the other day to .0015. Breaks that 🔑 and it goes 💥
0 · Reply
OckhamsRazor44
OckhamsRazor44 Jun. 11 at 2:48 PM
$SHMN Japenese Pharma talks resumed after patent protection?
0 · Reply
shortlongman
shortlongman Jun. 10 at 4:31 PM
$SHMN Buy?
0 · Reply
sohoonak
sohoonak Jun. 9 at 4:31 PM
$SHMN Anybody knows what's going on........is there any new contract!?
2 · Reply
OckhamsRazor44
OckhamsRazor44 Jun. 1 at 5:15 PM
$SHMN heading to .002 test
0 · Reply
Latest News on SHMN
No data available.
OckhamsRazor44
OckhamsRazor44 Jun. 29 at 6:12 PM
$SHMN Updates should be coming this summer
0 · Reply
OckhamsRazor44
OckhamsRazor44 Jun. 17 at 5:16 PM
$SHMN https://www.newswire.com/news/sohm-inc-awarded-european-patent-for-innovative-abbie-genome-editing-technology
0 · Reply
OckhamsRazor44
OckhamsRazor44 Jun. 17 at 5:16 PM
$SHMN This will come into play on SHMN sooner or later https://www.newswire.com/news/sohm-inc-awarded-european-patent-for-innovative-abbie-genome-editing-technology
0 · Reply
shortlongman
shortlongman Jun. 11 at 8:00 PM
$SHMN Or $TIPS
0 · Reply
OckhamsRazor44
OckhamsRazor44 Jun. 11 at 4:35 PM
$SHMN SHMN 💥 catalysts: "We are thrilled to introduce this game-changing technology to the world," said Dr. David Aguilar, Ph.D., SOHM’s COO. "Graphene nanoparticles have the potential to revolutionize genome editing, offering unprecedented precision and efficiency. We believe this breakthrough will have a profound impact on human health and open up new possibilities for scientific research as more gene therapies continue to pass FDA approvals."
0 · Reply
OckhamsRazor44
OckhamsRazor44 Jun. 11 at 2:50 PM
$SHMN 13M+ volume SHMN before 1 hour of trading. Someone loading. Something up. Someone or a group loading. Then 23M shares the other day to .0015. Breaks that 🔑 and it goes 💥
0 · Reply
OckhamsRazor44
OckhamsRazor44 Jun. 11 at 2:48 PM
$SHMN Japenese Pharma talks resumed after patent protection?
0 · Reply
shortlongman
shortlongman Jun. 10 at 4:31 PM
$SHMN Buy?
0 · Reply
sohoonak
sohoonak Jun. 9 at 4:31 PM
$SHMN Anybody knows what's going on........is there any new contract!?
2 · Reply
OckhamsRazor44
OckhamsRazor44 Jun. 1 at 5:15 PM
$SHMN heading to .002 test
0 · Reply
OckhamsRazor44
OckhamsRazor44 May. 28 at 4:01 PM
$SHMN https://share.google/XKBnPxhfz8LnbizSr
0 · Reply
OckhamsRazor44
OckhamsRazor44 May. 28 at 4:00 PM
$SHMN MORE PATENT APPROVALS COMING?
0 · Reply
OckhamsRazor44
OckhamsRazor44 May. 28 at 3:59 PM
$SHMN JAPANESE MERGER TALKS RESUMING?
0 · Reply
OckhamsRazor44
OckhamsRazor44 May. 26 at 6:25 PM
$SHMN https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Awarded-European-Patent-for-Innovative-ABBIE-Genome-Editing-Technology?id=475846
1 · Reply
Eugenius10
Eugenius10 Apr. 14 at 11:52 PM
$SHMN https://x.com/i/status/2044191692325302306
2 · Reply
RunsWitBulls
RunsWitBulls Jan. 12 at 2:38 PM
$SHMN watch this one closely. Buy, buy, buy on the dips.
0 · Reply
Sk782
Sk782 Dec. 13 at 5:44 PM
$RITE still confident in management’s ability to execute the plan. Planning to add more and hold until at least .05 $SHMN added more last week. Production is underway. A real gem with a low float- targeting at .20 $IMTL The management needs to remove Ballas from official OTC website. Most of .0001 had been sold out and only 43 millions left on .0002. Want to add if they bring Frank as official CEO. Targeting at .0150
1 · Reply
sohoonak
sohoonak Dec. 10 at 8:46 PM
$SHMN What's going on!? They were doing very well......who know the reason of nosing down!!??
0 · Reply
Sk782
Sk782 Nov. 19 at 5:52 PM
$IMTL waiting for Ballas to be out- will add 100 million shares if he’ll be out officially from OTC market website $RITE solid play- added more in 60s $SHMN accumulation phase- production of FDA approval products- .01 will come
0 · Reply
Eugenius10
Eugenius10 Nov. 16 at 5:51 PM
$SHMN Big things are coming.
0 · Reply